ZA202207808B - Veterinary anti-prolactin composition for ruminants used by intramammary administration - Google Patents
Veterinary anti-prolactin composition for ruminants used by intramammary administrationInfo
- Publication number
- ZA202207808B ZA202207808B ZA2022/07808A ZA202207808A ZA202207808B ZA 202207808 B ZA202207808 B ZA 202207808B ZA 2022/07808 A ZA2022/07808 A ZA 2022/07808A ZA 202207808 A ZA202207808 A ZA 202207808A ZA 202207808 B ZA202207808 B ZA 202207808B
- Authority
- ZA
- South Africa
- Prior art keywords
- intramammary administration
- ruminants
- veterinary anti
- prolactin
- composition
- Prior art date
Links
- 241000282849 Ruminantia Species 0.000 title 1
- 230000001263 anti-prolactin effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20305066 | 2020-01-27 | ||
| PCT/EP2021/051766 WO2021151897A1 (en) | 2020-01-27 | 2021-01-26 | Veterinary anti-prolactin composition for ruminants used by intramammary administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA202207808B true ZA202207808B (en) | 2023-03-29 |
Family
ID=69528716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2022/07808A ZA202207808B (en) | 2020-01-27 | 2022-07-13 | Veterinary anti-prolactin composition for ruminants used by intramammary administration |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20230063100A1 (https=) |
| EP (1) | EP4096428B1 (https=) |
| JP (1) | JP7624999B2 (https=) |
| KR (1) | KR20220132561A (https=) |
| CN (1) | CN115003164A (https=) |
| AR (1) | AR122365A1 (https=) |
| AU (1) | AU2021213891A1 (https=) |
| BR (1) | BR112022014708A2 (https=) |
| CA (1) | CA3165962A1 (https=) |
| ES (1) | ES2969031T3 (https=) |
| HU (1) | HUE064769T2 (https=) |
| IL (1) | IL294903A (https=) |
| MX (1) | MX2022009177A (https=) |
| UY (1) | UY39022A (https=) |
| WO (1) | WO2021151897A1 (https=) |
| ZA (1) | ZA202207808B (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526892A (en) | 1981-03-03 | 1985-07-02 | Farmitalia Carlo Erba, S.P.A. | Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas |
| FR2936710B1 (fr) * | 2008-10-07 | 2011-01-07 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
| FR2971423B1 (fr) * | 2011-02-15 | 2014-01-10 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
| CN106389964B (zh) * | 2016-11-21 | 2019-05-14 | 四川农业大学 | 一种奶牛回乳药物组合 |
| WO2019224149A1 (en) * | 2018-05-23 | 2019-11-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of an oral bolus in the drying-off of dairy cattle |
-
2021
- 2021-01-15 UY UY0001039022A patent/UY39022A/es not_active Application Discontinuation
- 2021-01-15 AR ARP210100104A patent/AR122365A1/es unknown
- 2021-01-26 AU AU2021213891A patent/AU2021213891A1/en active Pending
- 2021-01-26 ES ES21702016T patent/ES2969031T3/es active Active
- 2021-01-26 WO PCT/EP2021/051766 patent/WO2021151897A1/en not_active Ceased
- 2021-01-26 CA CA3165962A patent/CA3165962A1/en active Pending
- 2021-01-26 EP EP21702016.3A patent/EP4096428B1/en active Active
- 2021-01-26 HU HUE21702016A patent/HUE064769T2/hu unknown
- 2021-01-26 JP JP2022544228A patent/JP7624999B2/ja active Active
- 2021-01-26 CN CN202180010827.9A patent/CN115003164A/zh active Pending
- 2021-01-26 KR KR1020227028233A patent/KR20220132561A/ko active Pending
- 2021-01-26 MX MX2022009177A patent/MX2022009177A/es unknown
- 2021-01-26 US US17/793,324 patent/US20230063100A1/en active Pending
- 2021-01-26 BR BR112022014708A patent/BR112022014708A2/pt unknown
- 2021-01-26 IL IL294903A patent/IL294903A/en unknown
-
2022
- 2022-07-13 ZA ZA2022/07808A patent/ZA202207808B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4096428B1 (en) | 2023-10-11 |
| MX2022009177A (es) | 2022-08-17 |
| BR112022014708A2 (pt) | 2022-10-11 |
| CA3165962A1 (en) | 2021-08-05 |
| AU2021213891A1 (en) | 2022-08-18 |
| CN115003164A (zh) | 2022-09-02 |
| HUE064769T2 (hu) | 2024-04-28 |
| WO2021151897A1 (en) | 2021-08-05 |
| ES2969031T3 (es) | 2024-05-16 |
| AR122365A1 (es) | 2022-09-07 |
| IL294903A (en) | 2022-09-01 |
| JP7624999B2 (ja) | 2025-01-31 |
| JP2023511147A (ja) | 2023-03-16 |
| KR20220132561A (ko) | 2022-09-30 |
| EP4096428C0 (en) | 2023-10-11 |
| UY39022A (es) | 2021-07-30 |
| EP4096428A1 (en) | 2022-12-07 |
| US20230063100A1 (en) | 2023-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276197A (en) | Composition and method for reducing the neutrophil deficiency caused by chemotherapy through the administration of palinabolin and G-CSF factor | |
| ZA202210199B (en) | Glp-1 receptor agonist, pharmaceutical composition comprising same, and method for preparing same | |
| ZA202007678B (en) | Pharmaceutical combination, composition and combination formulation containing glucokinase activator and k-atp channel blocker, preparation method thereof and use thereof | |
| MY194087A (en) | Use of gabaa receptor reinforcing agent in preparation of sedative and anesthetic medicament | |
| PH12017501643A1 (en) | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations | |
| MX369818B (es) | Compuestos selectivos de peptido yy (pyy) y usos de los mismos. | |
| ZA202102039B (en) | Pharmaceutical compositions comprising rpl554 in hfa-134a for administration by inhalation | |
| EP4585219A3 (en) | Animal feed supplement and method | |
| MX375254B (es) | Una composición antimicrobiana farmacéutica o veterinaria intramamaria que comprende un poliéter ionóforo, o un uso de la misma para tratar mastitis. | |
| EP3019184A4 (en) | Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use | |
| IL276513A (en) | Quinolone analogs and their salts, preparations and method of using them | |
| PL3103351T3 (pl) | Środek dla przeżuwaczy do podawania doustnego i zawierająca go pasza dla przeżuwaczy | |
| PL3986514T3 (pl) | Urządzenie do podawania składnika do dróg oddechowych podmiotu | |
| EP3854417A4 (en) | COMPOSITION FOR VACCINE AGAINST SWINE FEVER AND METHOD FOR PREPARATION | |
| SG11202106906QA (en) | Composition for stabilizing vitamin c derivative by using gel structure | |
| UA103779C2 (ru) | Ветеринарная антипролактиновая композиция для жвачных | |
| EP3824888A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING FAB I INHIBITORS AND METHOD FOR PREPARING IT | |
| ZA202207808B (en) | Veterinary anti-prolactin composition for ruminants used by intramammary administration | |
| FR2971423B1 (fr) | Composition veterinaire antiprolactinique destinee aux ruminants | |
| EP3838246A4 (en) | DRUG MANAGEMENT METHOD FOR KIT FORMULATION REQUIRING DOSE ADJUSTMENT | |
| MX2013013182A (es) | Tratamiento de la mastitis. | |
| EP3875088A4 (en) | Package for medical composition containing anti-tumor agent | |
| MX2017014776A (es) | Combinacion farmaceutica de everolimus con dactolisib. | |
| NZ741384A (en) | Dopamine d3 receptor antagonists having a morpholine moiety | |
| MX2017001408A (es) | Derivados de serina como agonistas del receptor de grelina. |